Value of pulmonary function testing identifying progressive pulmonary disease in fibrotic sarcoidosis: results of a prospective feasibility study

Swigris JJ, Olson AL, Huie TJ et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 2011;183(11):1524-1530.

Nardi A, Brillet PY, Letoumelin P et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J 2011;38(6):1368-1373.

Kirkil G, Lower EE, Baughman RP. Predictors of Mortality in Pulmonary Sarcoidosis. Chest 2018;153(1):105-113.

Hunninghake GW, Costabel U, Ando M et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16(Sep):149-173.

Goh NS, Desai SR, Veeraraghavan S et al. Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008;177(11):1248-1254.

Baughman RP, Shlobin OA, Wells AU et al. Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. Respir Med 2018;139:72-78. doi: 10.1016/j.rmed.2018.04.015. Epub;%2018 May 5.:72-78.

Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159(1):179-187.

Pellegrino R, Viegi G, Brusasco V et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26(5):948-968.

Walsh SL, Wells AU, Sverzellati N et al. An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study. Lancet Respir Med 2014;2(2):123-130.

Wells AU, Desai SR, Rubens MB et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003;167(7):962-969.

Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007;132(1):207-213.

Patel AS, Siegert RJ, Creamer D et al. The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status. Thorax 2013;68(1):57-65.

de Vries J, Michielsen H, van Heck GL, Drent M. Measuring fatigue in sarcoidosis: the Fatigue Assessment Scale (FAS). Br J Health Psychol 2004;9(Pt 3):279-291.

Patel AS, Siegert RJ, Keir GJ et al. The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease. Respir Med 2013;107(9):1438-1443.

Papiris SA, Daniil ZD, Malagari K et al. The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir Med 2005;99(6):755-761.

Jeny F, Uzunhan Y, Lacroix M et al. Predictors of mortality in fibrosing pulmonary sarcoidosis. Respir Med 2020;169:105997. doi: 10.1016/j.rmed.2020.105997. Epub@2020 May 12.:105997.